The price of ZYXI is predicted to go up 7.59%, based on the high correlation periods with LECO. The similarity of these two price pattern on the periods is 91.16%.
ZYXI
LECO
Up: 7.59%Similarity: 91.16%
ZYXI Revenue Forecast
ZYXI EPS Forecast
ZYXI FAQs
What is revenue forecast for next quarter?
The market consensus for 's revenue in the upcoming quarter is projected to be approximately $53.457M USD.
RBC Capital analyst Shagun Singh lowered the firm's price target on Zynex to $11 from $12 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results. The firm's industry checks suggest that Q3 underlying utilization trends were positive despite typical summer seasonality driving a sequential step-down in elective procedures, the analyst tells investors in a research note. Investor sentiment is also positive for MedTech stocks going into the earnings season, and investors are likely to continue to chase winners and catalyst-driven names into year-end, RBC added.